News
3 Value Stocks That Look Undervalued After the Recent Market Pullback
At the end of October, the stock market had been up five straight months, leading many to declare it overvalued. Sure enough, the market experienced a sell-off in November that appears to be due to
The Smartest Growth Stock to Buy With $1,000 Right Now
We are still in a market led by growth stocks, and the biggest driving force in the stock market remains artificial intelligence (AI). The technology could prove to be the biggest technological
Should You Buy Ares Capital Corporation Stock While It's Below $21?
Over the past few decades, banks have stepped back from lending to specific segments of the economy, creating a massive opportunity for business development companies like Ares Capital Corporation
The Motley Fool Interviews Sezzle Co-Founder & CEO Charlie Youakim
At the annual Motley Fool member event, Motley Fool co-founder and CEO Tom Gardner talked with Sezzle co-founder and CEO Charlie Youakim about entrepreneurship, competition, and the business of buy
Prediction: This Will Be the Next Quantum Computing Stock That Berkshire Hathaway Buys
Over the last 60 years, Warren Buffett has built Berkshire Hathaway into one of the most successful investment firms in history. Berkshire's long-term compound annual gain of 20% is nearly double
1 Vanguard ETF I Keep Buying for My Kids
My kids don't care about stock tickers. They care about video games, soccer practice, and whether we're getting pizza for dinner. However, I care about their financial future -- and that's why I
Turning 62 Soon? Read This Social Security Warning.
When you turn 62, you hit an exciting milestone. You become eligible for Social Security benefits for the first time. It may be tempting to jump into claiming these benefits right away so you can
This $3 Billion Company Is Trading Like a Penny Stock
A major characteristic of penny stocks is their extreme volatility. Fortunes can be made in a matter of weeks with these stocks. But penny stocks can also make fortunes vanish just as quickly.
Right
This Family Office Acquired $148 Million of Karman Stock as Shares Tripled Since February IPO
Tulsa-based Schusterman Interests disclosed a new position in Karman Holdings (NYSE:KRMN) worth $148 million, according to its November 14 SEC filing.
Schusterman Interests reported a new position
Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO
Tulsa-based Schusterman Interests initiated a new position in HeartFlow, Inc. (NASDAQ:HTFL), acquiring over 1.9 million shares valued at $65.3 million, according to a November 14 SEC filing.
Better Artificial Intelligence Stock: SoundHound AI vs. Astera Labs
The rise of artificial intelligence (AI) has unleashed a tidal wave of related businesses to consider investing in. Among these are SoundHound AI (NASDAQ: SOUN) and Astera Labs (NASDAQ: ALAB).
The
Investor Dumps $10.9 Million in Grocery Outlet Stock as Shares Continue Multi-Year Downtrend
On November 14, Stadium Capital Management disclosed a complete exit from Grocery Outlet Holding Corp. (NASDAQ:GO), reducing its position by 877,860 shares in an estimated $10.9 million change.
GameStop vs. Beyond Meat: What Can These Meme Stock Rallies Teach Us?
The moniker "meme stock" was only created a few years ago. It was how Wall Street described GameStop (NYSE: GME), a struggling video game retailer that suddenly gained the attention of small
Prediction: Here's Where Nvidia Is Headed in 2026
Nvidia (NASDAQ: NVDA) has been one of the best stocks to own in 2023, 2024, and 2025. It has outperformed the market each year, and now that we're on the doorstep of 2026, investors are wondering if
Insperity Stock Down 55% From Highs as Hedge Fund Buys $13 Million Stake — Is It A Turnaround Bet?
Connecticut-based Stadium Capital Management initiated a new position in Insperity (NSP), adding 263,715 shares valued at approximately $13 million during the third quarter, according to a November
Enrolling in Medicare Advantage for 2026? Make Sure to Avoid These Big Mistakes.
At this point, there's only about another week left in Medicare's fall open enrollment period. So, if you still haven't narrowed down your choices for coverage in 2026, the time to get moving is
GitLab Stock Down 60% From Highs as Investor Sells 61,700 Shares — Is the Pullback a Buying Opportunity?
On November 14, Connecticut-based Stadium Capital Management disclosed a sale of 61,700 GitLab shares in the third quarter.
According to a Securities and Exchange Commission (SEC) filing dated
Jensen Huang Says This Artificial Intelligence Transition Will Be "Revolutionary"
Nvidia (NASDAQ: NVDA) has been at the forefront of advancements in artificial intelligence (AI) with its cutting-edge chips used in the latest technologies. While its sales growth has been slowing
Why a Hedge Fund Dumped Signet Stock Even as the Jeweler Lifted Its 2026 Outlook
On November 14, New York City-based Cooper Creek Partners Management disclosed in a U.S. Securities and Exchange Commission filing that it reduced its position in Signet Jewelers by about 890,000
History Says the Nasdaq Will Soar in 2026: The Best Stocks to Buy With $250 Before It Does
The Nasdaq Composite index has registered a gain of about 20% in 2025 so far, and that's quite impressive considering that the index endured a difficult start to the year and pulled back
5 Amazing Growth Stocks to Buy Before 2026
We're getting into the last stretch of the year, a time when many investors take stock of their holdings and see if their portfolios need any changes. If your portfolio needs some extra growth
This 7% Yielder Could Be a Top AI Play
Shares of the pharmaceutical giant Pfizer (NYSE: PFE) have suffered over the last three years, falling some 50% since December 2022. Shares have been weighed down by the collapse in revenue from its
This AI Infrastructure Play Could Double Your Money
It seems like most artificial intelligence (AI)-focused investors are turning to semiconductor players and hyperscalers as potential long-term opportunities. However, early-stage AI infrastructure
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs
New York City-based Cooper Creek Partners Management disclosed a new position in The Chemours Company (NYSE:CC) during the third quarter, adding nearly 4 million shares valued at $63.1 million


